Evaluation the efficacy of oral ondansetron on gag reflex in soft palate and palatine tonsil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201010254224N8

Enrollment

Registered

2011-01-27

Start date

2010-03-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gag reflex. Nausea and vomiting

Interventions

Intervention 1: Control : placebo ,tab. Intervention 2: Intervention : ondansetron,4mg,tab.

Prevention

Control : placebo ,tab

Intervention : ondansetron,4mg,tab

Eligibility

Sex/Gender

All

Age

15 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion critria: -ASA1 -No ban on taking ondansetron -Lack of any oral lesion and Mental disorders -signing the concent. Exculution Criteria: -pregnancy -Breastfeeding -gaserointestinal disorder -liver failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of gag reflex. Timepoint: Before and After Medication. Method of measurement: Gagging levels were recorded by 4-degree scale.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026